Clinical trial
Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 2
NCT04417218 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 2
- Lead sponsor
- Vanderbilt University Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 17, 2020
- Completion date
- January 1, 2023
- Enrollment
- 67 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy